USL-311 Uses, Dosage, Side Effects and more
USL-311 is under investigation in clinical trial NCT02765165 (Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)).
Trade Name | USL-311 |
Generic | USL-311 |
Type | |
Formula | C24H34N6O |
Weight | Average: 422.577 Monoisotopic: 422.279409739 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |